Document Detail

Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.
MedLine Citation:
PMID:  2452314     Owner:  NLM     Status:  MEDLINE    
Recently, this laboratory has demonstrated an enhanced susceptibility toward the development of lethal ventricular arrhythmias occurring in response to acute posterolateral ischemia in dogs with previous anterior myocardial infarction in the presence of therapeutic serum concentrations of digoxin. In the present study, acute posterolateral myocardial ischemia was produced in the absence of previous myocardial infarction in 15 digoxin-pretreated (1.19 +/- 0.21 ng/ml serum digoxin, 5-7 days pretreatment) and 11 vehicle-pretreated dogs. The incidences of sudden ventricular fibrillation and of 24 h arrhythmic mortality in response to posterolateral ischemia were 4/15 (27%) vs. 1/11 (9%) (p = 0.23) and 7/15 (47%) vs. 4/11 (36%) (p = 0.27) for digoxin- vs. vehicle-pretreated dogs, respectively. Ventricular ectopic activity at 24 and 48 h after the onset of posterolateral ischemia was reduced significantly by both intravenous lidocaine (1.0-5.0 mg/kg) and verapamil (50.0-500.0 micrograms/kg) in the vehicle-pretreated dogs, whereas neither antiarrhythmic agent significantly suppressed ventricular ectopy in the digoxin-pretreated dogs. The mean sizes for developing posterolateral myocardial infarctions (percentage of left ventricle) were greater for the digoxin-pretreatment group (31.9 +/- 2.8%) vs. vehicle-pretreatment group (14.8 +/- 2.0%, p less than 0.001). These findings suggest that uncomplicated acute myocardial ischemia in the presence of serum concentrations of digoxin that are considered clinically therapeutic may result in the development of larger areas of developing myocardial infarction and in the occurrence of ventricular arrhythmias that are less sensitive to suppression with conventional antiarrhythmic agents.
J J Lynch; B R Lucchesi
Related Documents :
22447974 - Effects of ventricular pacing protocol on electrical restitution assessments in guinea-...
6185774 - Effect of sulfinpyrazone on ventricular arrhythmia, prostaglandin synthesis, and catech...
7083504 - Serial evaluation of myocardial thickening and thinning in acute experimental infarctio...
3755634 - Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.
16835984 - Coronary artery bypass grafting in patients with left ventricular dysfunction.
22574544 - Utilizing a registry for st segment elevation myocardial infarction from a tertiary car...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  11     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1988 Feb 
Date Detail:
Created Date:  1988-05-27     Completed Date:  1988-05-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  193-203     Citation Subset:  IM    
Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109-0010.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arrhythmias, Cardiac / chemically induced*,  drug therapy
Coronary Disease / complications,  drug therapy*
Digoxin / blood,  therapeutic use,  toxicity*
Heart Rate / drug effects
Heart Ventricles
Infusions, Intravenous
Lidocaine / therapeutic use
Myocardial Infarction / complications,  drug therapy*
Verapamil / therapeutic use
Grant Support
Reg. No./Substance:
137-58-6/Lidocaine; 20830-75-5/Digoxin; 52-53-9/Verapamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Beta-adrenoreceptor antagonist potency and pharmacodynamics of ASL-8123, the primary acid metabolite...
Next Document:  Effect of adenosine triphosphate on canine renal circulation.